CoChat

The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.

Epidemiological Pathology of Dementia: Attributable-Risks at Death in the Medical Research Council Cognitive Function and Ageing Study

Open access

Abstract

BACKGROUND: Dementia drug development aims to modulate pathological processes that cause clinical syndromes. Population data (epidemiological neuropathology) will help to model and predict the potential impact of such therapies on dementia burden in older people. Presently this can only be explored through post mortem findings. We report the attributable risks (ARs) for dementia at death for common age-related degenerative and vascular pathologies, and other factors, in the MRC Cognitive Function and Ageing Study (MRC CFAS). METHODS AND FINDINGS: A multicentre, prospective, longitudinal study of older people in the UK was linked to a brain donation programme. Neuropathology of 456 consecutive brain donations assessed degenerative and vascular pathologies. Logistic regression modelling, with bootstrapping and sensitivity analyses, was used to estimate AR at death for dementia for specific pathologies and other factors. The main contributors to AR at death for dementia in MRC CFAS were age (18%), small brain (12%), neocortical neuritic plaques (8%) and neurofibrillary tangles (11%), small vessel disease (12%), multiple vascular pathologies (9%), and hippocampal atrophy (10%). Other significant factors include cerebral amyloid angiopathy (7%) and Lewy bodies (3%). CONCLUSIONS: Such AR estimates cannot be derived from the living population; rather they estimate the relative contribution of specific pathologies to dementia at death. We found that multiple pathologies determine the overall burden of dementia. The impact of therapy targeted to a specific pathology may be profound when the dementia is relatively "pure," but may be less impressive for the majority with mixed disease, and in terms of the population. These data justify a range of strategies, and combination therapies, to combat the degenerative and vascular determinants of cognitive decline and dementia. Please see later in the article for the Editors' Summary.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pmed.1000180

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 MRC CFAS design. Numbers of interviews and donations from interview waves.
Figure 1 MRC CFAS design. Numbers of interviews and donations from interview waves.CC BY · PubMed Central
Figure 2 MRC Alpha Study (Liverpool) design. Numbers of interviews and donations from each interview wave.
Figure 2 MRC Alpha Study (Liverpool) design. Numbers of interviews and donations from each interview wave.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 40 references

Cited by

See all 285

Metadata

Authors
Matthews, F. E., Brayne, C., Lowe, J., McKeith, I., Wharton, S. B., & Ince, P.
Affiliations
  • University of Cambridge (GB)
  • University of Nottingham (GB)
  • Newcastle University (GB)
  • University of Sheffield (GB)
Corresponding author
Ince, Paul
Venue
PLoS Medicine
Published
2009-11-10
Volume
6
Issue
11
Pages
e1000180
ISSN
  • 1549-1277 (ISSN-L)
  • 1549-1676
OpenAlex
W2039937642
Cited by
279
References
40
Citations by year
2026: 5 · 2025: 4 · 2024: 8 · 2023: 12 · 2022: 15 · 2021: 19 · 2020: 20 · 2019: 23 · 2018: 15 · 2017: 23 · 2016: 28 · 2015: 10 · 2014: 20 · 2013: 19 · 2012: 20
FWCI
11.51
Type
journal article
Language
en
Open access
Locations
  • PLoS Medicine (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Repository@Hull (Worktribe) (University of Hull) (submittedVersion, cc-by)
  • Newcastle University ePrints (Newcastle Univesity)
Funders
Medical Research Council (G9901400)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
Keywords
dementia, neuropathology, attributable risk, vascular pathology, cerebral small vessel disease, cerebral amyloid angiopathy, Lewy bodies, neurofibrillary tangles, hippocampal atrophy, brain donation, MRC Cognitive Function and Ageing Study, dementia burden, combination therapy
MeSH terms
Age Factors, Aged, Aged, 80 and over, Aging, Brain, Death, Dementia, Female, United Kingdom, Humans, Longitudinal Studies, Male, Organ Size, Prospective Studies, Risk Factors, Sensitivity and Specificity, Vascular Diseases, Logistic Models, Lewy Bodies, Cerebral Amyloid Angiopathy, Neurofibrillary Tangles

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Epidemiological Pathology of Dementia: Attributable-Risks at Death in the Medical Research Council Cognitive Function and Ageing Study. https://app.cochat.ai/papers/10.1371/journal.pmed.1000180
The paper
Matthews, F. E., Brayne, C., Lowe, J., McKeith, I., Wharton, S. B., & Ince, P. (2009). Epidemiological Pathology of Dementia: Attributable-Risks at Death in the Medical Research Council Cognitive Function and Ageing Study. PLoS Medicine. https://doi.org/10.1371/journal.pmed.1000180

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.